Biopharma Executive Rick Crowley Joins Novavax as Chief Operations Officer
21 déc. 2020 17h42 HE
|
Novavax, Inc.
GAITHERSBURG, Md., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 Vaccine
16 déc. 2020 19h08 HE
|
Novavax, Inc.
GAITHERSBURG, Md., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax Appoints Vaccine Industry Expert Margaret G. McGlynn to Board of Directors
09 déc. 2020 08h02 HE
|
Novavax, Inc.
GAITHERSBURG, Md., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax Announces COVID-19 Vaccine Clinical Development Progress
30 nov. 2020 06h30 HE
|
Novavax, Inc.
Pivotal Phase 3 trial in United Kingdom completes enrollmentPhase 2b efficacy trial in South Africa completes enrollment U.S./Mexico Phase 3 trial expected to begin in the coming weeks ...
Novavax to Participate in Upcoming Conferences
25 nov. 2020 16h15 HE
|
Novavax, Inc.
GAITHERSBURG, Md., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Novavax Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax to Host Conference Call for Questions Related to Third Quarter Financial and Operating Results on November 10, 2020
10 nov. 2020 09h18 HE
|
Novavax, Inc.
GAITHERSBURG, Md., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, will host a...
Novavax Reports Third Quarter 2020 Financial and Operational Results
09 nov. 2020 16h05 HE
|
Novavax, Inc.
Advanced clinical development of NVX‑CoV2373 with initiation of first Phase 3 trial to evaluate efficacy, safety and immunogenicityU.K. Phase 3 interim data expected as soon as early first quarter...
Novavax Appoints Gregory F. Covino as Chief Financial Officer and Announces Leadership Updates
09 nov. 2020 16h02 HE
|
Novavax, Inc.
Covino brings global biopharmaceutical finance experience to NovavaxJohn Trizzino, Chief Business Officer, takes on additional role as Chief Commercial OfficerFilip Dubovsky, M.D. promoted to...
Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA
09 nov. 2020 08h30 HE
|
Novavax, Inc.
GAITHERSBURG, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax and Commonwealth of Australia Announce Agreement in Principle for Acquisition of Novavax COVID-19 Vaccine
04 nov. 2020 09h52 HE
|
Novavax, Inc.
GAITHERSBURG, Md., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...